Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 24,802 | 20,835 | 21,711 | 21,616 | 19,649 |
| Cost of Goods | 2,743 | 2,837 | 3,326 | 2,547 | 3,145 |
| Gross Profit | 22,059 | 17,998 | 18,385 | 19,069 | 16,504 |
| Operating Expenses | 21,567 | 24,826 | 22,706 | 20,011 | 19,405 |
| Operating Income | 1,235 | -5,991 | -3,995 | -395 | -2,756 |
| Interest Expense | 3,051 | 1,476 | 0 | 0 | 0 |
| Other Income | 269 | 365 | 341 | 250 | 848 |
| Pre-tax Income | -1,547 | -7,102 | -3,654 | -145 | -1,908 |
| Net Income Continuous | -1,547 | -7,102 | -3,654 | -145 | -1,908 |
| Net Income | $-1,547 | $-7,102 | $-3,654 | $-145 | $-1,908 |
| EPS Basic Total Ops | -0.07 | -0.33 | -0.16 | -0.01 | -0.09 |
| EPS Basic Continuous Ops | -0.07 | -0.33 | -0.17 | -0.01 | -0.09 |
| EPS Diluted Total Ops | -0.07 | -0.33 | -0.16 | -0.01 | -0.09 |
| EPS Diluted Continuous Ops | -0.07 | -0.33 | -0.17 | -0.01 | -0.09 |
| EBITDA(a) | $3,846 | $-4,314 | $-3,163 | $1,908 | $-1,379 |